Serum glutathione reductase level as a disease activity biomarker in systemic lupus erythematosus: a single-centre preliminary study
Objectives This study aimed to investigate serum glutathione reductase (GR) levels in patients with SLE and to assess its association with disease activity.Methods The retrospective study collected clinical data, including serum GR, complement (C) 3 and C4 levels, among patients with SLE. The SLE Di...
Saved in:
| Main Authors: | Yan Sun, Leixi Xue, Zhichun Liu, Mengxue Yan, Siping Li |
|---|---|
| Format: | Article |
| Language: | English |
| Published: |
BMJ Publishing Group
2025-06-01
|
| Series: | Lupus Science and Medicine |
| Online Access: | https://lupus.bmj.com/content/12/1/e001593.full |
| Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
Serum lipid profile in systemic lupus erythematosus
by: Jingxiu Xuan, et al.
Published: (2025-01-01) -
The influence of periodontal status and serum biomarkers on salivary leptin levels in systemic lupus erythematosus patients
by: Leslie A. da Silva, et al.
Published: (2022-12-01) -
Cheminformatics Models for Inhibitors of Schistosoma mansoni Thioredoxin Glutathione Reductase
by: Sonam Gaba, et al.
Published: (2014-01-01) -
Measuring the rate of NADPH consumption by glutathione reductase in the cytosol and mitochondria.
by: Kenneth K Y Ting, et al.
Published: (2024-01-01) -
iTRAQ-based mass spectrometry screen to identify serum biomarkers in systemic lupus erythematosus
by: Ting Zhang, et al.
Published: (2024-05-01)